4
Changes in Ownership
Camp4 Therapeutics Corp Filed Acc 0001628280-25-016481
Options or other derivatives
- Chief Executive Officer acquired 160,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mandel-Brehm Josh · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +160,000 | 160,000 | D |
Loading xslF345X05/wk-form4_1743710748.xml…